Medivolve Stock Deutsche Boerse AG

4NC

CA58503M1014

Advanced Medical Equipment & Technology

End-of-day quote Deutsche Boerse AG 05/02/2024			5-day change	1st Jan Change
0.003000 ^EUR	-.--%		-80.00%	+500.00%

05-11	Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc.	RE
31/08/24	Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer	CI

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	233K 164K 145K 137K 124K 15.79M 235K 1.64M 631K 8.06M 618K 604K 25.9M	P/E 2022	-0.19x	P/E 2023	-0.02x
Enterprise Value	898K 633K 557K 526K 478K 60.82M 903K 6.31M 2.43M 31.05M 2.38M 2.33M 99.72M	EV / Sales 2022	22,007x	EV / Sales 2023	1,535,308x
Free-Float	94.14%	Yield 2022 *	-	Yield 2023	-

05-11	Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc.	RE
31/08/24	Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer	CI
31/08/24	Medivolve Inc. Announces Resignation of David Preiner as President	CI
01/06/24	Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/04/24	Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02/04/24	Medivolve Inc. Auditor Raises 'Going Concern' Doubt	CI
16/01/24	Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	CI
16/01/24	Medivolve Inc. Announces Management Changes	CI
17/11/23	Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director	CI
15/11/23	Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
07/11/23	Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors	CI
14/08/23	Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
16/05/23	Medivolve Inc. Establishes Medivolve Management Services, LLC in Puerto Rico	CI

31/08/24	Medivolve Announces Management Changes	AQ
13/02/24	Medivolve Announces Change of Auditor	AQ
16/01/24	Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors	AQ
17/11/23	Medivolve Announces Change of Auditor and Board Changes	AQ
07/11/23	Medivolve Announces Board Changes	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDIVOLVE	-.--%	-80.00%	-	-	2.7K
VEEVA SYSTEMS INC.	-0.26%	+7.59%	-3.55%	+38.70%	45.44B
PRO MEDICUS LIMITED	+0.71%	-4.38%	-46.27%	+101.03%	11.81B
SECTRA AB	+0.91%	-0.55%	-6.62%	+122.24%	5.54B
HEARTFLOW, INC.	+1.53%	-1.64%	+51.00%	-	4.28B
GENERATE BIOMEDICINES, INC.	-1.58%	-13.01%	-	-	1.94B
OMNICELL, INC.	+0.62%	+5.09%	+10.25%	-24.06%	1.54B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-3.21%	-5.10%	-37.64%	-	1.01B
ARBUTUS BIOPHARMA CORPORATION	+0.21%	-2.99%	+10.20%	+141.79%	960M
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD.	-0.68%	-6.41%	+30.07%	+32.80%	859M
Average	-0.23%	-2.17%	+0.93%	+68.75%	8.15B
Weighted average by Cap.	-0.29%	+3.42%	-7.18%	+56.79%

	2022	2023
Net sales	37.18 26.2 23.06 21.79 19.79 2.52K 37.38 260.96 100.54 1.29K 98.44 96.31 4.13K	0.69 0.48 0.43 0.4 0.37 46.48 0.69 4.82 1.86 23.73 1.82 1.78 76.21
Net income	-18.37M -12.95M -11.39M -10.76M -9.78M -1.24B -18.47M -129M -49.67M -635M -48.63M -47.58M -2.04B	-16.46M -11.6M -10.21M -9.64M -8.76M -1.11B -16.55M -116M -44.51M -569M -43.58M -42.64M -1.83B
Net Debt	-2.64M -1.86M -1.64M -1.55M -1.41M -179M -2.66M -18.57M -7.15M -91.44M -7M -6.85M -294M	665K 469K 413K 390K 354K 45.02M 669K 4.67M 1.8M 22.99M 1.76M 1.72M 73.83M

Medivolve Stock Deutsche Boerse AG

Stocks

4NC

CA58503M1014

Advanced Medical Equipment & Technology

Valuation: Medivolve

Latest news: Medivolve

Press Releases: Medivolve

Managers and Directors: Medivolve

Medical Software & Technology Services

Financials

Company Profile